Crossmark

Splicing factor <i> <scp>ESRP</scp> 1 </i> controls <scp>ER</scp> ‐positive breast cancer by altering metabolic pathways

Crossref DOI link: https://doi.org/10.15252/embr.201846078

Published Online: 2019-01-21

Published Print: 2019-02

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Gökmen‐Polar, Yesim https://orcid.org/0000-0001-9927-4893
Neelamraju, Yaseswini

Goswami, Chirayu P

Gu, Yuan

Gu, Xiaoping

Nallamothu, Gouthami

Vieth, Edyta

Janga, Sarath C https://orcid.org/0000-0001-7351-6268
Ryan, Michael

Badve, Sunil S https://orcid.org/0000-0001-8861-9980
Funding

Funding for this research was provided by:

Susan G. Komen
License Information

Version of Record valid from 2019-01-21
More Information

Publication History

Received: 2018-03-07

Accepted: 2018-12-11

Published: 2019-01-21